November 26, 2024

JP Mor­gan’s Mor­gan Health is round­ing out its first three years of in­vest­ing with its sev­enth in­vest­ment. The health ven­ture, which the … Sign up

Alec­tor re­port­ed a Phase 2 fail­ure for an Ab­b­Vie-part­nered Alzheimer’s pro­gram Mon­day af­ter­noon and said it will need to lay off staff. Re­searchers were ex­am­in­ing

Now that Pres­i­dent-elect Don­ald Trump has made his choice for FDA com­mis­sion­er, re­ac­tions and analy­sis are pour­ing in from bio­phar­ma ex­ec­u­tives and for­mer staffers who

Bris­tol My­ers Squibb’s cost-cut­ting ini­tia­tive will lead to ad­di­tion­al lay­offs in Lawrenceville, NJ, the com­pa­ny re­vealed this month in a state Sign up to read

The tran­si­tion team for Pres­i­dent-elect Don­ald Trump was still search­ing for its next Na­tion­al In­sti­tutes of Health di­rec­tor as re­cent­ly as last week, mul­ti­ple sources

Mer­ck is stop­ping a Phase 3 tri­al of its pul­monary ar­te­r­i­al hy­per­ten­sion treat­ment Win­re­vair al­most a year ear­ly fol­low­ing pos­i­tive in­ter­im da­ta, the com­pa­ny …

In­cyte’s mon­o­clon­al an­ti­body Mon­ju­vi re­duced cer­tain fol­lic­u­lar lym­phoma pa­tients’ risk of pro­gres­sion, re­lapse or death by 57% com­pared to place­bo, the com­pa­ny an­nounced Mon­day. …